(Q45101623)

English

Assessing short-term effects and costs at an early stage of innovation: the use of positron emission tomography on radiotherapy treatment decision making

scientific article published in January 2008

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Assessing short-term effects and costs at an early stage of innovation: the use of positron emission tomography on radiotherapy treatment decision making (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

decision making

1 reference

based on heuristic

inferred from title

2

object named as

Magali Morelle

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

author name string

Raphaël Remonnay

1

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Pascal Pommier

3

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Francesco Giammarile

4

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Marie-Odile Carrère

5

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 January 2008

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

International Journal of Technology Assessment in Health Care

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

24

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

212-220

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Cost-effectiveness of positron emission tomography for the management of potentially operable non-small cell lung cancer in Quebec

1 reference

https://api.crossref.org/works/10.1017%2FS026646230808029X

21 January 2018

Decision-tree sensitivity analysis for cost-effectiveness of whole-body FDG PET in the management of patients with non-small-cell lung carcinoma in Japan

1 reference

https://api.crossref.org/works/10.1017%2FS026646230808029X

21 January 2018

Accuracy and cost-effectiveness of [18F]-2-fluoro-deoxy-D-glucose-positron emission tomography scan in potentially resectable non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1017%2FS026646230808029X

21 January 2018

Positron-emission tomography and assessment of cancer therapy

1 reference

https://api.crossref.org/works/10.1017%2FS026646230808029X

21 January 2018

Marginal cost of operating a positron emission tomography center in a regulatory environment.

1 reference

https://api.crossref.org/works/10.1017%2FS026646230808029X

21 January 2018

Investing in new technology: the PET experience.

1 reference

https://api.crossref.org/works/10.1017%2FS026646230808029X

21 January 2018

Cost-effectiveness analysis of strategies introducing FDG-PET into the mediastinal staging of non-small-cell lung cancer from the French healthcare system perspective.

1 reference

https://api.crossref.org/works/10.1017%2FS026646230808029X

21 January 2018

Cost-effectiveness of FDG-PET in staging non-small cell lung cancer: the PLUS study.

1 reference

https://api.crossref.org/works/10.1017%2FS026646230808029X

21 January 2018

Cost-effectiveness of PET imaging in clinical oncology

1 reference

https://api.crossref.org/works/10.1017%2FS026646230808029X

21 January 2018

Cost-effectiveness of FDG-PET for staging non-small cell lung cancer: a decision analysis

1 reference

https://api.crossref.org/works/10.1017%2FS026646230808029X

7 January 2021

based on heuristic

inferred from DOI database lookup

Decision-tree sensitivity analysis for cost-effectiveness of chest 2-fluoro-2-D-[(18)F]fluorodeoxyglucose positron emission tomography in patients with pulmonary nodules (non-small cell lung carcinoma) in Japan

1 reference

https://api.crossref.org/works/10.1017%2FS026646230808029X

7 January 2021

based on heuristic

inferred from DOI database lookup

Primary staging of lymphomas: cost-effectiveness of FDG-PET versus computed tomography

1 reference

https://api.crossref.org/works/10.1017%2FS026646230808029X

7 January 2021

based on heuristic

inferred from DOI database lookup

Cost-effectiveness of whole-body PET imaging in non-small cell lung cancer and malignant melanoma

1 reference

https://api.crossref.org/works/10.1017%2FS026646230808029X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1017/S026646230808029X

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45101623&oldid=2065796879"